Later, overexpression of TRIM11 was found in high-grade gliomas, lung cancer, liver and pancreatic cancer with an oncogenic function promoting cell growth, migration, invasion and chemoresistance, suggesting TRIM11 as a novel target for tumour treatment [85]. This evidence concerns the gene TRIM11 and familial pancreatic carcinoma.